CN107158104B - Chewable tablet for enhancing immunity - Google Patents

Chewable tablet for enhancing immunity Download PDF

Info

Publication number
CN107158104B
CN107158104B CN201710302739.1A CN201710302739A CN107158104B CN 107158104 B CN107158104 B CN 107158104B CN 201710302739 A CN201710302739 A CN 201710302739A CN 107158104 B CN107158104 B CN 107158104B
Authority
CN
China
Prior art keywords
extract
wild jujube
enhancing immunity
jujube meat
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710302739.1A
Other languages
Chinese (zh)
Other versions
CN107158104A (en
Inventor
贾东升
谢晓亮
温春秀
崔施展
李荣乔
田伟
刘灵娣
边建波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUTE OF CASH CROPS HEBEI ACADEMY OF AGRICULTURE AND FORESTRY SCIENCES
Original Assignee
INSTITUTE OF CASH CROPS HEBEI ACADEMY OF AGRICULTURE AND FORESTRY SCIENCES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSTITUTE OF CASH CROPS HEBEI ACADEMY OF AGRICULTURE AND FORESTRY SCIENCES filed Critical INSTITUTE OF CASH CROPS HEBEI ACADEMY OF AGRICULTURE AND FORESTRY SCIENCES
Priority to CN201710302739.1A priority Critical patent/CN107158104B/en
Publication of CN107158104A publication Critical patent/CN107158104A/en
Application granted granted Critical
Publication of CN107158104B publication Critical patent/CN107158104B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines, and particularly relates to a chewable tablet for enhancing immunity. The chewable tablet for enhancing immunity is prepared by taking the wild jujube meat extract and the ginseng extract as active ingredients, has the characteristics of simple composition, low cost and obvious effect of enhancing immunity, is favorable for dissolving and absorbing the active ingredients by preparing the wild jujube meat extract and the ginseng extract into the chewable tablet, and is more convenient to take, has no bitter taste when in taking, has sour and sweet mouthfeel and high compliance of patients by selecting the type of a flavoring agent and the adding time.

Description

Chewable tablet for enhancing immunity
Technical Field
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a chewable tablet for enhancing immunity, and a preparation method and application thereof.
Background
Immunity is an important defense mechanism of the human body itself, and generally refers to the ability of the body to resist invasion of pathogenic microorganisms into the human body in medicine. In modern society, due to insufficient sleep, overstrain, lack of exercise, negative pessimistic psychological and dietary imbalance, etc., immunity of the body is easily lowered, so that viruses and the like are easily invaded, and various diseases such as cold, fatigue, gastrointestinal dysfunction and the like are caused continuously and for a long time.
At present, various medicines or health products for enhancing immunity are available, and compared with the single approach and single action target of western medicines, the traditional Chinese medicine emphasizes that a human body is a complete machine, focuses on the balance and regulation of immune functions, and has the advantages of multiple components and multiple targets. Therefore, the function of traditional Chinese medicine for improving the immune function of the body has been generally accepted. Known traditional Chinese medicines with the function of regulating immunity comprise lucid ganoderma, cordyceps sinensis, ginseng, codonopsis pilosula, radix sophorae flavescentis, honeysuckle, scutellaria baicalensis, radix rehmanniae, wolfberry, fructus psoraleae, poria cocos, shiitake mushrooms, schisandra chinensis, angelica sinensis, radix angelicae, ligusticum wallichii, gastrodia elata and the like, and the regulation of immunity by utilizing a traditional Chinese medicine formula is also reported in documents, for example, CN1682983A discloses a pharmaceutical composition for improving immunity, which comprises spina date seeds, lucid ganoderma and ginseng leaves; CN104383287A discloses a pharmaceutical composition for enhancing immunity, which is prepared from ginseng leaves, ginseng fruits, bletilla striata and spina date seeds. Because the traditional Chinese medicine advocates the compatibility of monarch, minister, assistant and guide and has the disadvantages of slow effect and the like, the traditional Chinese medicine usually adopts a formula containing a plurality of traditional Chinese medicines, has complex components, has poor taste and is usually required to be taken for a long time, and the compliance of taking the traditional Chinese medicine by a patient is greatly reduced.
The invention aims to provide the pharmaceutical composition for enhancing the immunity, which has the advantages of simple formula, obvious effect of enhancing the immunity and high patient compliance.
Disclosure of Invention
The invention aims to provide chewable tablets for enhancing immunity, which are prepared from active ingredients and pharmaceutically acceptable auxiliary materials, wherein the active ingredients consist of wild jujube meat extract and ginseng extract.
Preferably, the weight ratio of the wild jujube meat extract to the ginseng extract is 1-5: 3-1.
More preferably, the weight ratio of the wild jujube meat extract to the ginseng extract is 2-4: 2-1.
Most preferably, the weight ratio of the wild jujube meat extract to the ginseng extract is 3: 2.
The pharmaceutically acceptable auxiliary materials are selected from: one or more of fillers, binders, flavoring agents and lubricants.
Preferably, the filler is selected from: one or more of starch, lactose, microcrystalline cellulose, the binder being selected from: one or more of polyvinylpyrrolidone, ethanol and starch slurry, and flavoring agent selected from: one or more of mannitol, sorbitol, citric acid, glycyrrhizin and aspartame, and one or two of magnesium stearate and silica gel micropowder as lubricant.
More preferably, the flavoring agents are citric acid, glycyrrhizin and aspartame.
Most preferably, the weight ratio of citric acid, glycyrrhizin and aspartame is: 1-2: 3-5: 0.1-0.15.
Another object of the present invention is to provide a method for preparing chewable tablets for enhancing immunity, comprising the steps of:
(1) weighing the wild jujube meat extract and the ginseng extract according to the formula, mixing, adding the filler and the flavoring agent in a half amount of the formula, and uniformly stirring to obtain mixed powder for later use;
(2) adding binder into the mixed powder, making into soft material, granulating, drying, sieving with 10-20 mesh sieve, grading, adding lubricant and the rest correctant, and tabletting.
Still another object of the present invention is to provide a use of the meat extract of zizyphus jujube and the extract of ginseng for preparing chewable tablets for enhancing immunity.
Preferably, the weight ratio of the wild jujube meat extract to the ginseng extract is 1-5: 3-1.
More preferably, the weight ratio of the wild jujube meat extract to the ginseng extract is 2-4: 2-1.
Most preferably, the weight ratio of the wild jujube meat extract to the ginseng extract is 3: 2.
The invention has the beneficial effects that:
the medicine for enhancing immunity is simple in formula, only contains the wild jujube meat extract and the ginseng extract, but has a very obvious effect of enhancing immunity, and is even superior to similar medicines with more components.
Detailed Description
The invention may be further understood by reference to the following examples, which illustrate some methods of making or using. However, it is to be understood that these examples do not limit the present invention. Variations of the invention, now known or further developed, are considered to fall within the scope of the invention as described herein and claimed below.
Example 1: a chewable tablet for enhancing immunity is provided.
The composition comprises the following components in parts by weight:
3 parts of wild jujube meat extract, 2 parts of ginseng extract, 20 parts of microcrystalline cellulose, 1 part of polyvinylpyrrolidone, 0.1 part of citric acid, 0.4 part of glycyrrhizin, 0.01 part of aspartame and 0.06 part of magnesium stearate, and the preparation method comprises the following steps:
(1) weighing the wild jujube meat extract and the ginseng extract according to the formula, mixing, adding the filler and the flavoring agent in a half amount of the formula, and uniformly stirring to obtain mixed powder for later use;
(2) adding binder into the mixed powder, making into soft material, granulating, drying, sieving with 20 mesh sieve, grading, adding lubricant and the rest correctant, and tabletting.
Example 2: a chewable tablet for enhancing immunity is provided.
The composition comprises the following components in parts by weight:
2 parts of wild jujube meat extract, 2 parts of ginseng extract, 16 parts of microcrystalline cellulose, 1 part of polyvinylpyrrolidone, 0.1 part of citric acid, 0.4 part of glycyrrhizin, 0.01 part of aspartame and 0.06 part of magnesium stearate, and the preparation method is carried out according to the method in the example 1.
Comparative example 1: a chewable tablet for enhancing immunity is provided.
The composition comprises the following components in parts by weight:
3 parts of spina date seed extract, 2 parts of ginseng leaf extract, 1 part of lucid ganoderma, 20 parts of microcrystalline cellulose, 1 part of polyvinylpyrrolidone, 0.1 part of citric acid, 0.4 part of glycyrrhizin, 0.01 part of aspartame and 0.06 part of magnesium stearate, and the preparation method is carried out according to the method in the embodiment 1.
Comparative example 2: a chewable tablet for enhancing immunity is provided.
The composition comprises the following components in parts by weight:
5 parts of spina date seed extract, 20 parts of microcrystalline cellulose, 1 part of polyvinylpyrrolidone, 0.1 part of citric acid, 0.4 part of glycyrrhizin, 0.01 part of aspartame and 0.06 part of magnesium stearate, and the preparation method is carried out according to the method in the example 1.
Comparative example 3: a chewable tablet for enhancing immunity is provided.
The composition comprises the following components in parts by weight:
5 parts of ginseng extract, 20 parts of microcrystalline cellulose, 1 part of polyvinylpyrrolidone, 0.1 part of citric acid, 0.4 part of glycyrrhizin, 0.01 part of aspartame and 0.06 part of magnesium stearate, and the preparation method is carried out according to the method in the example 1.
Effect example 1: influence on mice hypoimmunity caused by cyclophosphamide
Experimental animals: 70 Kunming mice, males, weighing 21.0 + -2.3 g, were randomly divided into 7 groups, specifically a normal group, a blank group, an example 1 group, an example 2 group, a comparative example 1 group, a comparative example 2 group and a comparative example 3 group.
The experimental method comprises the following steps: after the mice are adaptively raised for 3 days, all the rest mice except a normal group are subjected to intraperitoneal injection of 40mg/Kg of cyclophosphamide for five consecutive days for modeling of a mouse model with low immunity, all the mice are subjected to intragastric administration from the 9 th day, wherein the normal group and a blank group are pure water, the administration amount of the corresponding drugs for intragastric administration of the groups of examples 1-2 and comparative examples 1-3 is 40mg/Kg, after one week of continuous administration, the weight of all the mice is weighed, then eyeballs are subjected to blood taking for routine test, the mice are killed by decapitation after blood taking, thymus and spleens are dissected and separated, weighed, and the organ index is calculated. Wherein the organ index is organ weight (mg)/body weight (g) × 100%.
The statistical method comprises the following steps:
SPSS17.0 statistical software is adopted, data are expressed by x +/-s (s is standard deviation), single factor analysis is adopted, Student's-ttest is adopted for comparison between two groups, variance analysis is adopted for comparison between the mean values of a plurality of samples, and P is less than 0.05 and is used as a significance test standard.
The experimental results are as follows:
the results of the effects of each group of experimental drugs on the hypoimmunity of mice caused by cyclophosphamide are shown in table 1.
TABLE 1 Effect on hypoimmunity in mice caused by Dry Cyclophosphamide
Figure BDA0001284293000000051
Note: p model group compared to normal group, examples 1-2, comparative examples 1-3 compared to model group, P < 0.05, P model group compared to normal group, examples 1-2, for examples 1-3 compared to model group, P < 0.01.
The experimental results in the table 1 show that the mice in the model group have weight loss, thymus index, spleen index and leukocyte number which are obviously reduced compared with the mice in the normal group, and the cyclophosphamide induced hypoimmunity model building of the mice is successful. Compared with the model group, the body weight of the mice of the groups of examples 1-2 and comparative examples 1-3 is increased, and the thymus index, the spleen index and the white blood cell number are increased to a certain extent, which shows that the medicaments of the examples 1-2 and the comparative examples 1-3 have certain effect of enhancing immunity, wherein the group of example 1 has the strongest immune enhancement effect, and the effect is even stronger than that of the group of comparative example 1 with more components and stronger than that of the groups of comparative examples 2-3 with only the wild jujube seed extract and the ginseng extract as the active components, which shows that the chewable tablets for enhancing the immunity with the wild jujube seed extract and the ginseng extract as the active components of the invention, although the composition is simpler, the wild jujube meat extract and the ginseng extract synergistically play a role in enhancing immunity, have a remarkable effect of enhancing immunity, and can be used for preventing and treating low immunity clinically.

Claims (3)

1. The chewable tablet for enhancing immunity is characterized by being prepared from the following components in parts by weight:
3 parts of wild jujube meat extract, 2 parts of ginseng extract, 20 parts of microcrystalline cellulose, 1 part of polyvinylpyrrolidone, 0.1 part of citric acid, 0.4 part of glycyrrhizin, 0.01 part of aspartame and 0.06 part of magnesium stearate, and the preparation method comprises the following steps:
(1) weighing the wild jujube meat extract and the ginseng extract according to the formula, mixing, adding microcrystalline cellulose serving as a filler and citric acid, glycyrrhizin and aspartame serving as corrigents half the formula amount, and uniformly stirring to obtain mixed powder for later use;
(2) adding binder polyvinylpyrrolidone into the mixed powder, making into soft material, granulating, drying, sieving with 20 mesh sieve, grading, adding lubricant magnesium stearate and the rest correctant, and tabletting.
2. The method of preparing an immune enhancing chewable tablet of claim 1 comprising the steps of:
(1) weighing the wild jujube meat extract and the ginseng extract according to the formula, mixing, adding microcrystalline cellulose serving as a filler and citric acid, glycyrrhizin and aspartame serving as corrigents half the formula amount, and uniformly stirring to obtain mixed powder for later use;
(2) adding binder polyvinylpyrrolidone into the mixed powder, making into soft material, granulating, drying, sieving with 10-20 mesh sieve, grading, adding lubricant magnesium stearate and the rest correctant, and tabletting.
3. Use of a wild jujube meat extract and a ginseng extract in the preparation of chewable tablets for enhancing immunity is characterized in that the weight ratio of the wild jujube meat extract to the ginseng extract is 3: 2.
CN201710302739.1A 2017-05-02 2017-05-02 Chewable tablet for enhancing immunity Active CN107158104B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710302739.1A CN107158104B (en) 2017-05-02 2017-05-02 Chewable tablet for enhancing immunity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710302739.1A CN107158104B (en) 2017-05-02 2017-05-02 Chewable tablet for enhancing immunity

Publications (2)

Publication Number Publication Date
CN107158104A CN107158104A (en) 2017-09-15
CN107158104B true CN107158104B (en) 2021-02-05

Family

ID=59813154

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710302739.1A Active CN107158104B (en) 2017-05-02 2017-05-02 Chewable tablet for enhancing immunity

Country Status (1)

Country Link
CN (1) CN107158104B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108606319A (en) * 2018-04-11 2018-10-02 陈剑军 A kind of immunopotentiator and its application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100674A (en) * 2009-12-16 2011-06-22 青岛康地恩药业有限公司 Febantel chewable tablets for dogs and cats

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102100674A (en) * 2009-12-16 2011-06-22 青岛康地恩药业有限公司 Febantel chewable tablets for dogs and cats

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
酸枣的药理研究综述;葛喜珍等;《首届全国干果生产与科研进展学术研讨会论文集》;19980930;第87-90页,尤其是第87页最后一段和第88页最后一段 *

Also Published As

Publication number Publication date
CN107158104A (en) 2017-09-15

Similar Documents

Publication Publication Date Title
CN105920085B (en) Composition with attenuation effect and preparation method and application thereof
CN103520370B (en) Blood sugar regulating drug
CN101239112B (en) Chinese medicinal composition for regulating blood fat and preparation thereof
WO2012027882A1 (en) Pharmaceutical composition for treating insomnia and preparation method thereof
CN106692297A (en) Composition for assistedly decreasing blood sugar, and preparation method and application thereof
CN106176918A (en) A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Radix Puerariae
CN102805774B (en) Chinese medicinal superfine powder for improving organism immunity of livestock and poultry and preparation method thereof
CN1879769A (en) Chinese medicinal preparation capable of increasing poultry immunity
CN107158104B (en) Chewable tablet for enhancing immunity
CN103977315B (en) Medicinal composition for treating cough with wind-heat affecting lung and preparation method thereof
CN107412665B (en) It is a kind of that there is Chinese medicine composition for relieving the effect of alcohol, preventing alcoholic liver injury and its preparation method and application
CN103623046A (en) Composite playing auxiliary protection role in chemical and alcoholic liver injury, preparation method of composite and application of composite in health-care food
CN106177432A (en) A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati
CN106177434A (en) A kind of Hyperglycemic health care compositions comprising Radix Puerariae and Rhizoma Polygonati Odorati
CN1243743A (en) Medicine for treating chronic hepatism and its preparing process
CN1947762A (en) Medicated composition with wt.-reducing and hypolipidemic functions
CN101491649B (en) Ginseng and astragalus pollen tablet and production method thereof
JPH11158077A (en) Composition having alleviating effect on stress
CN102485263B (en) Medicinal composition for treating chronic cough of children and its preparation method
CN111714539A (en) Liver-protecting composition and preparation method and application thereof
CN112791166B (en) Medicinal and edible composition for enhancing muscle performance and relieving exercise-induced fatigue
CN103893577B (en) A kind of compound gastrodia elata f. glauca tablet, preparation method and applications
CN104906339B (en) It is a kind of that there is the health food granule for improving sleep function
CN106376928A (en) Method for preparing compound dendrobium officinale health product assisting in reducing blood sugar
CN116236551B (en) Traditional Chinese medicine composition for treating spleen deficiency and excessive dampness syndrome type spleen stomach diseases and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant